Navigation Links
Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA

nd other filings with the SEC, including the "Risk Factors" sections of such reports.

Any forward-looking statements are made pursuant to Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and, as such, speak only as of the date made. Micromet and MedImmune undertake no obligation to publicly update any forward- looking statements, whether as a result of new information, future events or otherwise.

CONTACT: MedImmune: Investors, Peter Vozzo, Director, Investor Relations,+1-301-398-4358, or Media, Kate Barrett, Manager, Public Relations,+1-301-398-4320; or Micromet: Company, Chris Schnittker, SVP & CFO,+1-267-242-3151, ; or Investors,Susan Noonan, +1-212-966-3650, , or Media, Pat Garrison,+1-917-322-2567, christopher.schnittker@micromet-inc.com susan@sanoonan.com pgarrison@rxir.com

Web site: http://www.micromet-inc.com/http://www.medimmune.com/

Ticker Symbol: (NASDAQ-NMS:MITI),(NASDAQ-NMS:MEDI)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
4. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
5. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
6. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
7. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
8. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
9. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
10. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
11. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
Post Your Comments:
(Date:10/6/2008)...he door to the understanding of and possible ...ancer, BILLERICA, Mass., Oct. 6 /- S...the first ever analytical instrument for the,kinet... and cytoplasmic,glycolysis in cells in a 96 well ...ing cellular bioenergetics have been relatively un...
(Date:10/6/2008)...tudies with Durezol Dosed Prior to Surgery, TAMPA..., Inc., a,privately held ophthalmic-focused biopha...TM) (difluprednate ophthalmic emulsion) 0.05% is n...oved by the U.S. Food and,Drug Administration in J...ndicated for the treatment of inflammation and pai...
(Date:10/6/2008)...ll Scheduled for 9:00 AM ET Today -, SEATTLE, Oct... (Nasdaq:,DNDN) announced today that it has comple...andomized, double-blind, placebo-controlled IMPACT...ent, also known as D9902B),clinical trial designed...ational active cellular immunotherapy PROVENGE(R) ...
(Date:10/6/2008)...at drinking polyphenol-rich 100% Concord grape,jui...ergy intake or body,weight, CONCORD, Mass., Oct. ...phenol-rich Concord grape juice did not cause sign...es in appetite and was shown to reduce waist,circu...th Annual Meeting of,the American College of Nutri...
Breaking Medicine Technology:Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference 2642 1New Benefactors Show Support for CDA4CDT 3A 2638 1New Benefactors Show Support for CDA4CDT 3A 2638 2New Benefactors Show Support for CDA4CDT 3A 2638 3New Benefactors Show Support for CDA4CDT 3A 2638 4New Benefactors Show Support for CDA4CDT 3A 2638 5New Benefactors Show Support for CDA4CDT 3A 2638 6New Benefactors Show Support for CDA4CDT 3A 2638 7Newly discovered virus linked to deadly skin cancer 9721 1Newly discovered virus linked to deadly skin cancer 9721 2Newly discovered virus linked to deadly skin cancer 9721 3Newly discovered virus linked to deadly skin cancer 9721 4Gene That Creates Cerebral Cortex Discovered 9718 1
...ly to subsequently,respond, have substantially mor...ange in treatment strategy, COLORADO SPRINGS, Colo...ta presented at the 2007 International Congress on...sychotic drug,response be assessed earlier than is...zophrenia treatment paradigm for when to,evaluate ...
...ector National,Alliance on Mental Illness (NAMI), ...ire/ -- Today,the Archives of General Psychiatry p...ial treatments for bipolar disorder,"Psychosocial...w up,study to one released last Thursday in the Ne...tidepressants in the treatment of,bipolar disorder...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Latest NIMH Study on Bipolar Disorder 2Latest NIMH Study on Bipolar Disorder 3
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...e-to-speech" project in Singapore is using a custo...ally improve the lives of the intellectually disab...ing with homemade pictures, the handheld innovatio...express their needs in such everyday tasks as orde...
...reated with Interferon (IFN)to treat chronic hepa... during treatment phase itself//. Retinopathy can ...tment, says the researchers in a study published ...gy & Visual Science (IOVS)in the January 2007 iss...
...t government-run hospitals in Rajasthan will now h...instead of a brand name//, according to Health Min...this regard to all government medical colleges, ho...ntres, community health centres and dispensaries,"...
...y dwellings were thought to be far cleaner and hea...itish researchers say this is not true- inner citi.... Market analysts CACI and TNS analyzed smoking a... understand the unhealthiest places in England, Wa...
Other Medicine News:
... magnification for advanced surgical procedures. P...ven at the highest magnification. 3.5x, 4.5x and 5...ion is ideal for surgical applications. Precision ...duce a superior image. The compact abd lightweight...
... high power negative lens delivering magnification...system is ease of use. Movement whilst maintaining...depth of field. The ultra lightweight aluminum bar... stability for the mounted loupes and optimal foca...
Keeler Galilean loupes are ideal for general dental and surgical work when increased magnification and a large field of view of required., ,Keeler loupes are laser aligned, lightweight and comfor
Used for maintaining and forming the anterior chamber by the injection and removal of fluids, air miotics, and viscoeastic substances, as well as keeping the cornea moist during surgery. 4 mm from be
Medicine Products: